LA Jolla Pharma (LJPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 09-2004 | 06-2004 | 03-2004 | 12-2003 | |
| Operating Expenses | 11,017 | 12,936 | 8,465 | 8,319 | 8,511 |
| Operating Income | -11,017 | -12,936 | -8,465 | -8,319 | -8,511 |
| Other Income | 48 | 104 | 97 | -56 | 71 |
| Pre-tax Income | -10,969 | -12,832 | -8,368 | -8,375 | -8,440 |
| Net Income Continuous | -10,969 | -12,832 | -8,368 | -8,375 | -8,440 |
| Net Income | $-10,969 | $-12,832 | $-8,368 | $-8,375 | $-8,440 |
| EPS Basic Total Ops | -2.90 | -0.21 | -0.14 | -0.15 | -3.54 |
| EPS Basic Continuous Ops | -2.90 | -0.21 | -0.14 | -0.15 | -3.54 |
| EPS Diluted Total Ops | -2.90 | -0.21 | -0.14 | -0.15 | -3.54 |
| EPS Diluted Continuous Ops | -2.90 | -0.21 | -0.14 | -0.15 | -3.54 |
| EBITDA(a) | $-10,472 | $-12,315 | $-7,940 | $-7,901 | $-8,044 |